Ameriprise’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$793K Buy
85,990
+1,233
+1% +$11.4K ﹤0.01% 3333
2025
Q1
$727K Buy
84,757
+17,947
+27% +$154K ﹤0.01% 3316
2024
Q4
$718K Buy
66,810
+3,243
+5% +$34.8K ﹤0.01% 3360
2024
Q3
$361K Buy
63,567
+85
+0.1% +$483 ﹤0.01% 3581
2024
Q2
$268K Sell
63,482
-730
-1% -$3.08K ﹤0.01% 3619
2024
Q1
$327K Buy
64,212
+9,560
+17% +$48.7K ﹤0.01% 3559
2023
Q4
$509K Buy
54,652
+18,277
+50% +$170K ﹤0.01% 3444
2023
Q3
$238K Buy
36,375
+2,914
+9% +$19.1K ﹤0.01% 3648
2023
Q2
$272K Sell
33,461
-15
-0% -$122 ﹤0.01% 3635
2023
Q1
$287K Sell
33,476
-174
-0.5% -$1.49K ﹤0.01% 3625
2022
Q4
$312K Buy
33,650
+13,895
+70% +$129K ﹤0.01% 3572
2022
Q3
$203K Buy
19,755
+2,350
+14% +$24.1K ﹤0.01% 3698
2022
Q2
$174K Buy
17,405
+300
+2% +$3K ﹤0.01% 3703
2022
Q1
$211K Sell
17,105
-5,860
-26% -$72.3K ﹤0.01% 3743
2021
Q4
$398K Sell
22,965
-13,000
-36% -$225K ﹤0.01% 3587
2021
Q3
$645K Sell
35,965
-26,195
-42% -$470K ﹤0.01% 3315
2021
Q2
$1.42M Sell
62,160
-30,965
-33% -$708K ﹤0.01% 3062
2021
Q1
$1.39M Buy
93,125
+24,725
+36% +$370K ﹤0.01% 2995
2020
Q4
$369K Buy
68,400
+35,645
+109% +$192K ﹤0.01% 3430
2020
Q3
$149K Buy
32,755
+17,685
+117% +$80.4K ﹤0.01% 3593
2020
Q2
$74K Sell
15,070
-1,735
-10% -$8.52K ﹤0.01% 3601
2020
Q1
$53K Sell
16,805
-4,200
-20% -$13.2K ﹤0.01% 3578
2019
Q4
$54K Buy
21,005
+5,005
+31% +$12.9K ﹤0.01% 3665
2019
Q3
$19K Buy
+16,000
New +$19K ﹤0.01% 3676